Patel N, et al. - In this systematic review and meta-analysis of 13 studies, including 820 participants, researchers determined, in advanced heart failure (HF) patients, the impacts of left ventricular assist device (LVAD) implantation on indicators of diabetes mellitus (DM) control. They identified these studies via a systematic search of MEDLINE and Cochrane through October 2017. They pooled the outcomes of interest (glycosylated hemoglobin A1c [HbA1c], fasting glucose, daily insulin requirements, and body mass index). Findings demonstrated significant improvement in HbA1c, fasting plasma glucose, and daily insulin need relative to LVAD implantation in advanced HF patients.